Clinical trial
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
NCT06802861 is registered in ClinicalTrials.gov with University of Tennessee Graduate School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
- Lead sponsor
- University of Tennessee Graduate School of Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gestational complications, gestational diabetes, gestational diabetes mellitus in pregnancy, obesity and obesity-related medical conditions, preeclampsia, preeclampsia (pe), preeclampsia (pe) risk, pregnancy, pregnancy complications